Lambrolizumab
Get a Quick Quote Now
Select Packaging
Product Description
Product
Lambrolizumab
CAS
1374853-91-4
Formula
C6504-H10004-N1716-O2036-S46
Synonym
Immunoglobulin G4, anti-(human protein PDCD1 (programmed cell death 1)) (human-Mus musculus monoclonal heavy chain), disulfide with human-Mus musculus monoclonal light chain, dimer, Lambrolizumab, UNII-DPT0O3T46P, Immunoglobulin G4, anti-(human programmed cell death 1); humanized mouse monoclonal (228-L-proline(H10-S>P))gamma 4 heavy chain (134-218')-disulfide with humanized mouse monoclonal kappa light chain dimer (226-226'':229-229'')- bisdisulfide
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Notes
Lambrolizumab is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
Lambrolizumab
Product Description
Product
Lambrolizumab
CAS
1374853-91-4
Formula
C6504-H10004-N1716-O2036-S46
Synonym
Immunoglobulin G4, anti-(human protein PDCD1 (programmed cell death 1)) (human-Mus musculus monoclonal heavy chain), disulfide with human-Mus musculus monoclonal light chain, dimer, Lambrolizumab, UNII-DPT0O3T46P, Immunoglobulin G4, anti-(human programmed cell death 1); humanized mouse monoclonal (228-L-proline(H10-S>P))gamma 4 heavy chain (134-218')-disulfide with humanized mouse monoclonal kappa light chain dimer (226-226'':229-229'')- bisdisulfide
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Notes
Lambrolizumab is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
